Le Lézard
Classified in: Health
Subject: SVY

Cancer Treatment Centers of America® Ranks Among Top US Hospitals in 2017 BrandIndex Rankings


BOCA RATON, Fla., Oct. 16, 2017 /PRNewswire/ -- Cancer Treatment Centers of America® (CTCA), a national network of five hospitals headquartered in Boca Raton, Fla., ranked third in the US Hospitals category of YouGov's 2017 Brand Health rankings. The 2017 ranking derived from respondents' rating of 42 nationally-recognized hospitals and hospital systems on six important brand metrics: quality, value, impression, satisfaction, reputation and willingness to recommend. CTCA® ranked behind only Mayo Clinic and Johns Hopkins, and ahead of Cedars-Sinai, Cleveland Clinic and Memorial Sloan-Kettering, among others. The results were based on a national survey of 13,207 adults over 18 years of age polled between July 1, 2016 and June 30, 2017.

Cancer Treatment Centers of America(R) (PRNewsfoto/Cancer Treatment Centers of Ame)

"This ranking reflects the expertise of our more than 4,600 clinicians and fellow Stakeholders (employees), and their commitment to deliver the exceptional quality of care for which CTCA is renowned," said Peter Yesawich, Chief Growth Officer of CTCA.

"Cancer Treatment Centers of America continues its work against a disease that touches so many Americans," said YouGov BrandIndex CEO Ted Marzilli. "The brand's high rating reflects its commitment to providing high quality care to patients from around the US."

About YouGov BrandIndex 
YouGov BrandIndex (www.brandindex.com) is the only daily consumer perception research service of brands, taking more than 4,800 interviews every day from a representative US population sample, and more than 1.5 million interviews per year. Respondents are drawn from an online panel of more than 1.8 MM US adults aged 18+.

About Cancer Treatment Centers of America® 
Cancer Treatment Centers of America Global, Inc. (CTCA) is a national network of five hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa specializing in the treatment of adult patients with cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, chemotherapy and immunotherapy, with supportive therapies designed to manage side effects and enhance quality of life both during and after treatment. Our patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. CTCA is also rated one of the most admired hospital systems in the U.S. in national consumer surveys. Visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter for more information.

Contact: 
Abigail Obre 
[email protected] 
(561) 923-3198

SOURCE Cancer Treatment Centers of America


These press releases may also interest you

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...



News published on and distributed by: